Alvotech (ALVO) IV/HV History

Comparing implied volatility to historical (realized) volatility reveals whether options are priced rich or cheap relative to actual price movement. Persistent gaps can signal trading opportunities.

Alvotech (ALVO) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry, with a market capitalization near $1.05B, listed on NASDAQ, employing roughly 1,012 people, carrying a beta of 0.21 to the broader market. Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. Led by Lisa Graver, public since 2022-06-16.

IV/HV history compares implied volatility to realized volatility over time. No recent options activity for ALVO as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how implied vs realized volatility is reported and how to read the data →